Pulmonary Tuberculosis Treatment Failure in Coastal Poasia: Determinants from a Case-Control Study [Accepted]

Fitri Rachmillah Fadmi, sri Mulyani, Karol Octrisdey, Wa Ode Sitti Justin, Yeni Riza

Abstract


Tuberculosis remains a public health concern, particularly in coastal communities where access to healthcare services is limited and social conditions differ from other settings. This study aimed to examine factors associated with pulmonary tuberculosis treatment failure at the primary healthcare level in coastal areas. A case-control design was applied, involving 48 participants consisting of 24 cases and 24 controls. Data were obtained from the tuberculosis program registry and structured interviews. Bivariate analysis using the chi-square test was conducted to identify candidate variables (p ≤ 0.25), followed by binary logistic regression. The findings showed that treatment adherence was the only factor that remained associated with treatment failure after adjustment for other variables (AOR = 14.81; p = 0.016). Other variables, including distance to health facilities, knowledge, history of comorbid disease, family support, anxiety, and the role of the treatment supervisor (PMO), were not statistically significant in the multivariable analysis, although some showed a tendency toward association. These results suggest that successful tuberculosis treatment is not determined solely by clinical conditions but is closely related to patients’ consistency in following treatment. Strengthening adherence should therefore be a key priority to improve treatment outcomes, particularly in coastal communities.


References


World Health Organization. Global Tuberculosis Report 2024. Geneva: World Health Organization; 2024.

MacNeil A, Glaziou P, Sismanidis C, Date A, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward meeting global targets. Lancet Infect Dis. 2020;20(4):440–54.

Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia Tahun 2024. Jakarta: Kementerian Kesehatan RI; 2024.

Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, et al. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis. Lancet Infect Dis. 2018;18(9):e307–18.

Jomidava T, Khogali M, Sereda Y, Avaliani Z, Davitashvili M, Madzgharashvili M, et al. Does optimized adherence support improve treatment outcomes in RR/MDR-TB patients on 18–20 months regimen in Tbilisi, Georgia? J Infect Dev Ctries. 2021;15(91):34S.

Chakrabartty A, Basu P, Ali KM, Sarkar AP. Determinants of treatment outcome in tuberculosis patients. J Fam Med Prim Care. 2019;8(11):3648–52.

Tesema GA, Teshale AB, Workie DL. Prevalence and determinants of unsuccessful tuberculosis treatment outcomes: A systematic review and meta-analysis. BMJ Open. 2021;11(7):e047350.

Doltu S, Ciobanu A, Sereda Y, Persian R, Ravenscroft L, Kasyan L, et al. Short and long-term outcomes of video observed treatment in tuberculosis patients, the Republic of Moldova. J Infect Dev Ctries. 2021;15(09.1):17S-24S.

Story A. Tuberculosis Treatment and Adherence. In: Migliori GB, Raviglione MC, editors. Essential Tuberculosis. Cham: Springer International Publishing; 2021. doi:10.1007/978-3-030-66703-0_19

Teferi MY, El-Khatib Z, Boltena MT, Andualem AT, Asamoah BO, Biru M, et al. Tuberculosis treatment outcome and predictors in Africa: a systematic review and meta-analysis. J Environ Res Public Health. 2021;18(20):10678.

Opperman C, Singh S, Ghebrekristos Y, Warren R, Goosen W. Pulmonary non-tuberculous mycobacteria and Mycobacterium tuberculosis complex co-infection: A pragmatic approach to its diagnosis and management in South Africa. S Afr Med J. 2024;114(9):12–3.

Southeast Sulawesi Provincial Health Office. (2024). Provincial health profile of Southeast Sulawesi, 2024. Kendari, Indonesia: Southeast Sulawesi Provincial Health Office.

Kendari City Health Office. (2024). Tuberculosis program report of Kendari City, 2024. Kendari, Indonesia: Kendari City Health Office.

Poasia Primary Health Center. (2024). Tuberculosis program report of Poasia Primary Health Center, 2024. Kendari, Indonesia: Poasia Primary Health Center.

Macpherson L, Miller C, Hamada Y, Rangaka L, Ruhwald M, Falzon D, et al. Policies, practices, opportunities and challenges for tuberculosis screening: a global survey of national tuberculosis programmes. BMJ Glob Health. 2025 .

Sulis G, Tavaziva G, Gore G, Benedetti A, Solomons R, van Toorn R, et al. Comparative effectiveness of regimens for drug-susceptible tuberculous meningitis in children and adolescents: a systematic review and aggregate-level data meta-analysis. In: Open forum infectious diseases. Oxford University Press US; 2022 .

Rickman HM, Phiri MD, Feasey HR, Krutikov M, Shao H, Horton KC, et al. Sex differences in the risk of Mycobacterium tuberculosis infection: a systematic review and meta-analysis of population-based immunoreactivity surveys. Lancet Public Health. 2025;10(7):e588–98.

Montsi S. The epidemiology and treatment outcomes of tuberculosis cases in Lesotho between 2009 and 2019. 2022.

Maynard C, Tariq S, Sotgiu G, Migliori GB, van den Boom M, Field N. Psychosocial support interventions to improve treatment outcomes for people living with tuberculosis: a mixed methods systematic review and meta-analysis. EClinicalMedicine. 2023.

Yanes-Lane M, Trajman A, Bastos ML, Oxlade O, Valiquette C, Rufino N, et al. Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation. BMC Public Health. 2021. doi:10.1186/s12889-021-10195-z

Fadmi FR et al. Correlation between individual characteristics and smear-positive pulmonary tuberculosis in Puuwatu Health Center, Kendari City. Indones J Health Sci Res Dev. 2021.

Fadmi FR, others. Logistic regression analysis for pulmonary tuberculosis related to environmental factors in Katobu Health Centre. Indones J Health Sci Res Dev. 2025.

McNabb KC, others. Travel distance to tuberculosis treatment and its impact on loss to follow-up. BMC Public Health. 2024;24:578.

Bonsa Z, Tadesse M, Bekele E, Abeba G, Solomon E, Husen M, et al. Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Southwestern Oromia, Ethiopia: ten-year retrospective analysis. BMC Infect Dis. 2024. doi:10.1186/s12879-024-10205-6

Arja A, Godana W, Hassen H, Bogale B. Patient delay and associated factors among tuberculosis patients in Gamo zone public health facilities, Southern Ethiopia: An institution-based cross-sectional study. PloS One. 2021;16(7):e0255327.

Meiyanti S et al. Treatment Adherence among Tuberculosis Patients. J Multidiscip Healthc. 2024.

Boutilier JJ, Jónasson JO, Yoeli E. Improving tuberculosis treatment adherence support: the case for targeted behavioral interventions. Manuf Serv Oper Manag. 2022;24(6):2925–43.

Teo AKJ, Singh SR, Prem K, Hsu LY, Yi S. Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis. Respir Res. 2021 doi:10.1186/s12931-021-01841-6

Dememew Z, Deribew A, Zegeye A, Janfa T, Kegne T, Alemayehu Y, et al. A high burden of infectious tuberculosis cases among older children and young adolescents of the female gender in Ethiopia. Trop Med Infect Dis. 2025;10(3):79.

Magee MJ, Khakharia A, Gandhi NR, Day CL, Kornfeld H, Rhee MK, et al. Increased risk of incident diabetes among individuals with latent tuberculosis infection. Diabetes Care. 2022;45(4):880–7.

Alinaitwe et al. B. Family support and tuberculosis treatment adherence. Sci Rep. 2025.

Loveday M, Hlangu S, Larkan LM, Cox H, Daniels J, Mohr-Holland E, et al. “This is not my body”: Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis. PLoS One. 2021;16(10):e0251482.

Sweetland AC, Mann CG, Fernandes MJ, Matsuzaka C, De Silva FV, Lee J, et al. Leveraging Social Networks to Integrate Depression Treatmentinto Primary Health and Tuberculosis Care in Brazil. Curr Psychiatry Res Rev. 2024. doi:10.2174/0126660822243332230921052022

Sun G, Wang K, Li X, Yin T, Hu H, Zhang L, et al. Construction of Health Education Prescriptions for Patients with Tuberculosis. In: Proceedings of the 2024 International Conference on Smart Healthcare and Wearable Intelligent Devices. Guangzhou Guangdong China: ACM; 2024. doi:10.1145/3703847.3703896

Plokhykh V, Duka M, Cassidy L, Chen CY, Malakyan K, Isaakidis P, et al. Mental health interventions for rifampicin-resistant tuberculosis patients with alcohol use disorders, Zhytomyr, Ukraine. J Infect Dev Ctries. 2021;15(09.1):25S-33S.

Wagnew F, Gray D, Tsheten T, Kelly M, Clements AC, Alene KA. Effectiveness of nutritional support to improve treatment adherence in patients with tuberculosis: a systematic review. Nutr Rev. 2024;82(9):1216–25.

Farhat M, Cox H, Ghanem M, Denkinger CM, Rodrigues C, Abd El Aziz MS, et al. Drug-resistant tuberculosis: a persistent global health concern. Nat Rev Microbiol. 2024;22(10):617–35.


Refbacks

  • There are currently no refbacks.




____________________________________________________________________________________________________________________________________________

Health Dynamics || Open Access Journal || Online version only || Publisher: Knowledge Dynamics || ISSN: 3006-5518 (online) || Contact: healthdynamics.journal@gmail.com; +8801814901991; +6282136364408